Overview

A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy, safety and Population Pharmacokinetic (PPK) of morinidazole and sodium chloride injection with levofloxacin hydrochloride and sodium chloride injection sequential of levofloxacin hydrochloride tablets in women with pelvic inflammatory disease: An Open-Lable Multicenter Prospective Non-Randomized Trial
Phase:
Phase 4
Details
Lead Sponsor:
Jiangsu Hansoh Pharmaceutical Co., Ltd.